Atherosclerosis Cardiovascular Disease
16
7
7
1
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 65/100
6.3%
1 terminated out of 16 trials
50.0%
-36.5% vs benchmark
19%
3 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (16)
Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis
Oral Microbiome in Carotid Atherosclerosis
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Associations Between Dietary Patterns, LDL Aggregation, and Cardiometabolic Health: A Cross-sectional Analysis.
Comparative Effects of Carnivore and Mediterranean-style Diets on LDL Aggregation and Cardiometabolic Health
Erythrodiol in Pomace Olive Oil as a Protective Agent Against Atherosclerosis
Deciphering the Effect of Moderate Wine Consumption on Healthy Aging Through Postprandial Extracellular Vesicles.
Lipoprotein (a) and Vascular Regenerative Cell Content
Evaluation of the Association Between the Effects of Generalized Stage 3 and 4 Periodontitis on Arterial Stiffness and Cardiovascular Risk: the PAROCAR Study
Evaluating Atherosclerotic Disease Progression in Patients With Diabetes Mellitus
[18F]AlF-NOTA-octreotide PET/MRI in Carotid Artery Disease
The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease
Randomized Comparison of Morning Versus Bedtime Administration of Statins: A Cardiovascular Circadian Chronotherapy (C3) Trial
Effect of Icosapent-ethyl Ester (IPE) to Reduce the Residual Risk Cardiovascular Disease.
Variability in Human Fatty Acids Profiles Based on Blood Fractions and Metabolic Conditions
Social Engagement Strategies to Improve Medication Adherence